Methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate
C29H30FN3O4 — CID 171685110
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate
Methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate (PubChem CID 171685110) has the molecular formula C29H30FN3O4 and a molecular weight of 503.57 g/mol. Its IUPAC name is methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate |
|---|---|
| PubChem CID | 171685110 |
| Molecular Formula | C29H30FN3O4 |
| Molecular Weight | 503.57 g/mol |
| Exact Mass | 503.22 |
| IUPAC Name | methyl N-[3-[4-[4-[3-(2-fluorophenyl)propanoylamino]phenyl]piperidine-1-carbonyl]phenyl]carbamate |
| SMILES | COC(=O)Nc1cccc(C(=O)N2CCC(c3ccc(NC(=O)CCc4ccccc4F)cc3)CC2)c1 |
| InChI | InChI=1S/C29H30FN3O4/c1-37-29(36)32-25-7-4-6-23(19-25)28(35)33-17-15-21(16-18-33)20-9-12-24(13-10-20)31-27(34)14-11-22-5-2-3-8-26(22)30/h2-10,12-13,19,21H,11,14-18H2,1H3,(H,31,34)(H,32,36) |
| InChIKey | RZZIZYSAWRAFJV-UHFFFAOYSA-N |
| XLogP | 5.60 |
| TPSA | 87.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 503.57 |
| LogP ≤ 5 | 5.60 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171685110 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.